JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Protokół
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Ubiquitination is a key posttranslational modification carried out by a set of three enzymes. Mutations of genes involved in this modification are associated with many different human diseases. Here, we describe protocols to detect protein ubiquitination in cultured cells in vivo and test tubes in vitro.

Streszczenie

Ubiquitination, the covalent attachment of the polypeptide ubiquitin to target proteins, is a key posttranslational modification carried out by a set of three enzymes. They include ubiquitin-activating enzyme E1, ubiquitin-conjugating enzyme E2, and ubiquitin ligase E3. Unlike to E1 and E2, E3 ubiquitin ligases display substrate specificity. On the other hand, numerous deubiquitylating enzymes have roles in processing polyubiquitinated proteins. Ubiquitination can result in change of protein stability, cellular localization, and biological activity. Mutations of genes involved in the ubiquitination/deubiquitination pathway or altered ubiquitin system function are associated with many different human diseases such as various types of cancer, neurodegeneration, and metabolic disorders. The detection of altered or normal ubiquitination of target proteins may provide a better understanding on the pathogenesis of these diseases.  Here, we describe protocols to detect protein ubiquitination in cultured cells in vivo and test tubes in vitro. These protocols are also useful to detect other ubiquitin-like small molecule modification such as sumolyation and neddylation.

Protokół

Detection of protein ubiquitination in cultured cells

  1. Transfect cultured cells with plasmids expressing the protein of interest and (epitope-tagged version of) ubiquitin.
  2. Make complete cell lysis buffer (2% SDS, 150 mM NaCl, 10 mM Tris-HCl, pH 8.0) with 2mM sodium orthovanadate, 50 mM sodium fluoride, and protease inhibitors.
  3. Lyse cells with 100 µl cell lysis buffer per plate (6 cm dish). If a larger dish is used, adjust volume accordingly.  Swirl the dish carefully to let the lysis buffer cover the entire area of grown cells.
  4. Collect the cells with a cell scraper and transfer the cell lysates into a 1.5 ml eppendorf tube. Place the tube onto a hot plate immediately to boil for 10 min.
  5. Shear the cells with a sonication device.
  6. Add 900ul of dilution buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton). Incubate samples at 4°C for 30-60 min with rotation.
  7. Spin the diluted samples at 20,000 x g for 30 min. Transfer the resulting supernatant to a new eppendorf tube. Be careful not to disturb the pellet.
  8. Measure the protein concentration.
  9. Prepare Protein A- or G-agarose bead-conjugated antibody against the target protein in a compatible buffer (50% slurry). Cut the narrow end of a P-200 pipette tip and transfer 14-20 μl of resin to 500-1,500 μg of prepared cell lysates for immunoprecipitation. For cells with high transfection efficiency, 500 μg will be enough. For cells with low transfection efficiency, more protein may be needed.
  10. Incubate the cell lysate-bead mixture at 4°C overnight with rotation.
  11. Spin down the beads at 5000 x g for 5 min. Aspirate the supernatant. Wash the resin with the washing buffer (10 mM Tris-HCl, pH 8.0, 1 M NaCl, 1 mM EDTA, 1% NP-40) twice.
  12. Spin the beads for a final time at 20,000 x g for 30 sec. Aspirate the residual washing buffer and boil the resin with 2X SDS loading buffer.
  13. Load samples onto a SDS-PAGE gel for immunoblotting analysis.
  14. Detect ubiquitin and the target protein with respective antibodies. For immunoblotting, we generally detect ubiquitin first. The membrane will then be used to detect the protein precipitated.

Detection of ubiquitination on target protein through In vitro ubiquitination assay

  1. Make 5X ubiquitination buffer (100 mM Tris-HCl, pH 7.5, 25 mM MgCl2, 2.5 mM DTT, 10 mM ATP). Store them in small aliquots at -20 °C for up to 6 month. Some protocols also add creatine phosphate and creatine kinase into the buffer for ATP regeneration 1,2.
  2. For each reaction, prepare a mixture containing the following:
    8 μl5X ubiquitination buffer
    250 ngubiquitination E1
    500 ngubiquitination E2
    0.5 μgubiquitin
    0.5 μgprotein of interest
     water to 40 μl total volume
    As controls, prepare similar reactions in the absence of either E1, E2, or ubiquitin.
  3. Incubate the mixture at 37°C for 1 hour or longer.
  4. Stop the reaction by adding SDS-PAGE sample buffer and boil the sample for 10 min.
  5. Load samples onto SDS-PAGE gel for immunoblotting analysis.
  6. Detect ubiquitin and the target protein with respective antibodies.

Access restricted. Please log in or start a trial to view this content.

Dyskusje

In this presentation, we first described steps that permit detecting ubiquitin modification on a protein of interest in cultured mammalian cells. In order to detect ubiquitination specifically on the protein of interest, not on non-covalently interacting proteins, we used a stringent condition for cell lysis, immunoprecipitation and washing 1,3.  Ubiquitination, detected by immunoprecipitation of target protein in such a harsh condition followed by anti-ubiquitin immunoblotting, is therefore likely to be ...

Access restricted. Please log in or start a trial to view this content.

Ujawnienia

The authors have nothing to disclose.

Podziękowania

This work was supported by NIH grants RO1 DC006497, RO1 NS057289, and PO1 ES016738 (to Z. Zhang); California Institute for Regenerative Medicine grants RS1-00331-1 and RL1-00682-1 (to Z. Zhang); the American Parkinson Disease Association (to Z. Zhang and Y. S. Choo); and the Michael J. Fox Foundation for Parkinson’s Research (Z. Zhang).

Access restricted. Please log in or start a trial to view this content.

Odniesienia

  1. Xiong, H. PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest. 119, 650-660 (2009).
  2. Xirodimas, D. P., Saville, M. K., Bourdon, J. C., Hay, R. T., Lane, D. P. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell. 118, 83-97 (2004).
  3. Didier, C. RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization. Mol Cell Biol. 23, 5331-5345 (2003).
  4. Laney, J. D., Hochsetrasser, M. Unit 14.5 Analysis of Protein Ubiquitination. Current Protocols in Protein Science. , 14.5.1-14.5.11 (2002).

Access restricted. Please log in or start a trial to view this content.

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Protein UbiquitinationPosttranslational ModificationUbiquitin activating Enzyme E1Ubiquitin conjugating Enzyme E2Ubiquitin Ligase E3Deubiquitylating EnzymesProtein StabilityCellular LocalizationBiological ActivityGene MutationsHuman DiseasesCancerNeurodegenerationMetabolic DisordersPathogenesisDetection ProtocolsCultured Cells In VivoTest Tubes In VitroSumolyationNeddylation

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone